AXSM
Axsome Therapeutics Inc
196.00$
+1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +23.8% | +4.8% | +16.2% | +20.2% | +13.4% | +2.3% | +23.5% | +14.0% | +14.6% | -2.4% | +14.2% | – | |
| – | +13.0% | -14.7% | +27.9% | +4.7% | +24.6% | -6.9% | +37.4% | -11.4% | +3.5% | +19.4% | -7.9% | – | |
| – | +25.1% | +7.1% | +15.2% | +21.8% | +12.4% | +3.2% | +22.3% | +16.5% | +15.5% | -3.9% | +16.1% | – | |
| – | +7.1% | +19.6% | +35.4% | -9.0% | +21.2% | -18.6% | +10.6% | -18.9% | +21.5% | +8.0% | -12.2% | – | |
| – | +13.8% | +19.6% | -2.3% | +30.5% | -8.9% | +38.7% | -21.9% | +15.4% | +55.6% | +9.3% | +12.5% | – | |
| – | +43.3% | -16.3% | +15.6% | +1.1% | +13.8% | -6.8% | +2.8% | +18.4% | +3.9% | +12.5% | +6.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.3% | +54.1% | +20.1% | +52.3% | +11.7% | +10.0% | -24.6% | -38.9% | +4.6% | +1.1% | +30.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.